Faes Farma, S.a.

Tania González García

Gonzalo Hernández Herrero

Neftalí García Domínguez

Pablo Morán Poladura

Arturo Zazpe Arce

Paloma Tato Cerdeiras

Yagamare Fall Diop

Hugo Santalla García

Álvaro Ganza González

Fátima Garrido Fernández

Ana Gonzalo Gorostiza

Tatiana María Suárez Cortés

Generosa Gómez Pácios

The invention relates to an aqueous pharmaceutical composition comprising: The invention also relates to said compositions for use in the treatment and/or prevention of a disorder or disease susceptible to amelioration by antagonism of Hhistamine receptor and/or of a corticosteroid-responsive disease through nasal administration. The invention also relates to a process for preparing the aqueous pharmaceutical composition above mentioned.

Aqueous compositions comprising bilastine and mometasone

The invention relates to new intermediates in the synthesis of Eldecalcitol and to processes for the preparation of said intermediates and of Eldecalcitol.

Process and intermediates for the preparation of eldecalcitol

The invention relates to a process for preparing a compound of (III)   Compounds of formula (III) are key intermediates in the synthesis of Bilastine.

Process and intermediates for the preparation of bilastine

Growing community of inventors

Vizcaya, Spain

Tania González García